Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs73061622 | chr19:49358111 | C/T | 1.25E-12 | 175 | 16.18 | 13.5 | 1.37 | KM Plot |
| PAAD | rs73061627 | chr19:49360418 | C/T | 3.0E-12 | 170 | 16.18 | 13.13 | 1.37 | KM Plot |
| PAAD | rs73061632 | chr19:49361663 | G/A | 5.92E-13 | 178 | 16.2 | 12.4 | 1.37 | KM Plot |
| PAAD | rs73061643 | chr19:49368151 | A/G | 7.3E-13 | 176 | 16.28 | 12.6 | 1.37 | KM Plot |
| PAAD | rs73061656 | chr19:49372355 | G/A | 6.19E-13 | 176 | 16.2 | 12.4 | 1.37 | KM Plot |
| PAAD | rs73061658 | chr19:49372376 | G/C | 6.19E-13 | 176 | 16.2 | 12.4 | 1.37 | KM Plot |
| PAAD | rs73061659 | chr19:49373556 | G/A | 6.19E-13 | 176 | 16.2 | 12.4 | 1.37 | KM Plot |
| PAAD | rs73102394 | chr1:227576152 | C/T | 6.61E-5 | 176 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs73108447 | chr12:53275614 | G/A | 0 | 176 | 15.62 | 13.47 | 1.03 | KM Plot |
| PAAD | rs73108453 | chr12:53276900 | A/G | 0 | 176 | 15.62 | 13.47 | 1.03 | KM Plot |
| PAAD | rs73108457 | chr12:53277367 | A/G | 0 | 176 | 15.62 | 13.47 | 1.03 | KM Plot |
| PAAD | rs73181916 | chr12:104751021 | T/A | 1.01E-12 | 177 | 15.53 | 15.57 | 1.37 | KM Plot |
| PAAD | rs73181919 | chr12:104755922 | C/T | 1.01E-12 | 177 | 15.53 | 15.57 | 1.37 | KM Plot |
| PAAD | rs73181926 | chr12:104757208 | T/G | 1.01E-12 | 177 | 15.53 | 15.57 | 1.37 | KM Plot |
| PAAD | rs73212335 | chr3:197131473 | C/T | 9.48E-7 | 176 | 15.62 | 14.3 | 1.78 | KM Plot |